Overview

Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This purpose of this study is to evaluate the safety and efficacy of treatment with nasal CO2 in the treatment of pain and other symptoms related to temporomandibular disorder (TMD).
Phase:
Phase 2
Details
Lead Sponsor:
Capnia, Inc.